Ketimix Cream contains Ketoconazole 2% w/w, an antifungal agent belonging to the imidazole class, indicated for the treatment of various superficial fungal infections of the skin. Ketoconazole exerts its therapeutic effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to increased membrane permeability and ultimately fungal cell death. Ketimix Cream is effective against dermatophytes, yeasts such as Candida species, and Malassezia furfur, making it suitable for conditions including tinea corporis, tinea cruris, tinea pedis, seborrheic dermatitis, and candidiasis of the skin. The cream should be applied topically to the affected area once or twice daily, as directed by a healthcare professional, typically for a duration of 2 to 4 weeks depending on the severity and type of infection. Patients should ensure the skin is clean and dry before application and avoid contact with eyes and mucous membranes. Adverse effects are generally mild and may include local irritation, burning sensation, or itching. Ketimix Cream is contraindicated in individuals with known hypersensitivity to ketoconazole or any component of the formulation. Use during pregnancy and lactation should be under medical supervision. Proper adherence to treatment and hygiene measures is essential to achieve optimal therapeutic outcomes and prevent recurrence.